ICON plc
  • Services

    Services

    Our services span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global programs.

    Read More
    Services
    Adaptive TrialsClinical Research ServicesConsultingEarly PhaseFunctional Services ProvisionLaboratoriesLanguage ServicesMedical ImagingReal World IntelligenceValue Access Outcomes
    Site and patient identification, enrolment and engagement.
    Site & Patient Solutions

    Site and patient identification, enrolment and engagement.

    Integrated services that cover planning, management, execution and analysis.
    Clinical Research Services

    Integrated services that cover planning, management, execution and analysis.

  • Sectors

    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read More
    Sectors
    BiosimilarsBiotechGovernment & Public Health SolutionsMedical DevicePharmaceuticals
    The new EU medical and in vitro diagnostic device regulations go into effect at the start of 2020. Are you ready?
    EU MDR/IVDR Regulations

    The new EU medical and in vitro diagnostic device regulations go into effect at the start of 2020. Are you ready?

    Strategies and recommendations to achieve optimal market access.
    Making sense of the Biosimilars market

    Strategies and recommendations to achieve optimal market access.

  • Therapeutics

    Therapeutics

    We have extensive experience in a broad range of therapeutic areas. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators.

    Read More
    Therapeutics
    CardiovascularCell and Gene TherapiesCentral Nervous SystemEndocrine & Metabolic DisordersGenomicsInfectious DiseasesInternal Medicine & ImmunologyMedical DeviceOphthalmologyRare & Orphan DiseasesTransplant ImmunologyWomen's Health
    ICON has conducted hundreds of clinical studies in both solid and haematological tumours, including experience with CAR-T therapies.
    Oncology

    ICON has conducted hundreds of clinical studies in both solid and haematological tumours, including experience with CAR-T therapies.

    ICON has recently led the development of 14 vaccines resulting in FDA/EMA approvals.
    Vaccines

    ICON has recently led the development of 14 vaccines resulting in FDA/EMA approvals.

  • Innovation

    Innovation

    We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs.

    Read More
    Innovation
    FIRECRESTIntel Pharma Analytics PlatformDrug Safety Reporting SolutionOne SearchEvidence PlatformFLEX ADVANTAGE Medical Imaging TechnologyNONMEM ICONIKPDx-POPIMRAPubsHub
    Using data to design, simulate, and analyse adaptive clinical trials with ease.
    ADDPLAN®

    Using data to design, simulate, and analyse adaptive clinical trials with ease.

    Connecting patients with the right trial in the right location.
    Patient Engagement Portal

    Connecting patients with the right trial in the right location.

  • Insights

    Insights

    BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.

    Read More
    Insights
    Digital Disruption Patient CentricityTransforming TrialsValue Based HealthcareBlogVideosWebinar Channel
    Remote monitoring and leveraging wearable devices and sensors in clinical trials.
    mHealth & Wearables

    Remote monitoring and leveraging wearable devices and sensors in clinical trials.

    Reduce post market study costs with Real World Data.
    Real World Data

    Reduce post market study costs with Real World Data.

  • News & Events

    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read More
    News & Events
    Press ReleasesIn the NewsEventsMediakitSocial MediaAwards
    27 - 28 January, 2020
    Patients as Partners Europe

    27 - 28 January, 2020

    Visit the Webinar Channel
    On-Demand Webinars

    Visit the Webinar Channel

  • About ICON

    About ICON

    Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life.

    Read More
    About ICON
    Company HistoryICON in Asia PacificICON in Latin AmericaLeadership
    We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
    Quality

    We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.

    Partners Making a Difference.
    ICON and You

    Partners Making a Difference.

  • Careers
  • Investors
  • Investigators
  • Patients
  • Contact
  • EN | 日本語
  1. Home
  2. News & Events
  3. Press Releases

Press Releases

  • 25 February 2015

    ICON Reports Fourth Quarter and Full Year 2014 Results and Issues 2015 Earnings Guidance

    In the fourth quarter net revenue grew 13.0% year on year to $390.

  • 2 February 2015

    ICON to Acquire MediMedia Pharma Solutions

    The acquisition strengthens ICON’s expertise in scientific communications and market access

  • 29 January 2015

    ICON Creates New Global Innovation Hub to Advance Clinical Development

    The hub will create 200 scientific, IT and business jobs in Ireland

  • 10 June 2010

    ICON Launches Innovative Safety Application

    Real-time data enables physicians to respond faster to safety signals.

  • 1
  • ...
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
In this section
In this section
  • Press Releases
  • In the News
  • Events
    • Industry Events
      • ISPOR EU 2019
    • Webinars
    • Workshops
  • Mediakit
    • Facts and Figures
    • ICON Spokespeople
  • Social Media
  • Awards
  • Patients as Partners Europe
  • On-Demand Webinars

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media

What’s happening in ICON

ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Services
  • Insights
  • Innovation
ICON For
  • Investigators
  • Mediakit
  • Volunteers
  • Investors
  • Jobs & Careers
News & Events
  • Press Releases
  • Events
  • ICON on Social Media
  • LinkedIn
  • Twitter
  • Facebook
  • Youtube
  • © 2020 ICON plc
  • Disclaimer
  • Privacy
  • Site Cookies

Connect with us

Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media